During the development of DCM, excessive hyperglycemia can cause an increase in reactive oxygen species, which activate NF-κB and subsequently trigger the activation of NLRP3, driving cellular inflammation and apoptosis [21]. This evidence concerns the gene NLRP3 and Hyperglycemia.